Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Allodepleted T-cell ImmunotheRapeutics

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
ABSTRACT Conventional systemic immunotherapy administration often results in insufficient anti‐tumor immune response and adverse… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Review
2018
Review
2018
Passive immunotherapy has emerged as a very promising approach for the treatment of Alzheimer’s disease and other… Expand
  • table 1
  • table 1
  • figure 1
2015
2015
Prothymosin alpha (ProTα) is a conserved mammalian polypeptide with intracellular functions associated with cell proliferation… Expand
2011
2011
Monoclonal antibodies (mAbs) to HER2 are currently used to treat breast cancer, but low clinical efficacy, along with primary and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
Medical countermeasures to prevent or treat smallpox are needed due to the potential use of poxviruses as biological weapons… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2005
2005
United Biomedical, Inc. (UBI) has developed a set of core technologies for the discovery and production of synthetic peptide… Expand
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • table 3
Highly Cited
1997
Highly Cited
1997
Elevated levels of the p53 protein occur in ∼50% of human malignancies, which makes it an excellent target for a broad-spectrum T… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
1997
1997
Elevated levels of the p53 protein occur in , 50% of human malignancies, which makes it an excellent target for a broad-spectrum… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
1990
1990
Chemiluminescence was used as an indicator for phagocytic activity of granulocytes induced by zymosan in whole blood. Luminol was… Expand